Asthma drug could halve chance of developing Parkinson’s

News

Author: Parkinson's Life editorsPublished: 28 September 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Asthma medication

A recent study has found that a drug most commonly used for asthma may cut the chances of developing Parkinson’s.

The research, carried out by Harvard Medical School, Massachusetts, US, found that those who inhaled salbutamol – a drug found in inhalers – were half as likely to develop the condition.

In Parkinson’s disease, a protein named a-synuclein accumulates in various brain cells and can be fatal. To counter this, the research team grew human nerve cells and tested over 1000 medications, finding results to suggest salbutamol could cut the production of a-synuclein.

Neurologist Anthony Lang, who works at the University of Toronto, Canada, said the results were “fascinating” and “had come out of the blue”.

Despite some encouraging developments, Clemens Scherzer, who was a part of the research team, said clinical trials were “a few years off”.

Go Back

Share this story

Comments


Related articles


Faces-of-parkinsons-cover

Carers' Corner

Faces of Parkinson’s: “His facial expressions have changed, but not the sparkle in his eyes”

Personal portraits of people with Parkinson’s

READ MORE
SURVEY-2016-lead

Global update

Take the Parkinson’s Life survey for a chance to win!

Parkinson’s Life 2016 Survey: tell us what you think

READ MORE

Perspectives

Parkinson’s website could put lives at risk, says clinical director of Parkinson’s UK

Claims made by Fight Parkinson’s are “absolutely unsubstantiated”

READ MORE